{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:26:59Z","timestamp":1784824019828,"version":"3.55.0"},"reference-count":166,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Coordination for the Improvement of Higher Education Personnel (CAPES)","award":["2020\/15833-1"],"award-info":[{"award-number":["2020\/15833-1"]}]},{"name":"S\u00e3o Paulo Research Foundation (FAPESP)","award":["2020\/15833-1"],"award-info":[{"award-number":["2020\/15833-1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Antibody-based passive immunotherapy has been used effectively in the treatment and prophylaxis of infectious diseases. Outbreaks of emerging viral infections from arthropod-borne viruses (arboviruses) represent a global public health problem due to their rapid spread, urging measures and the treatment of infected individuals to combat them. Preparedness in advances in developing antivirals and relevant epidemiological studies protect us from damage and losses. Immunotherapy based on monoclonal antibodies (mAbs) has been shown to be very specific in combating infectious diseases and various other illnesses. Recent advances in mAb discovery techniques have allowed the development and approval of a wide number of therapeutic mAbs. This review focuses on the technological approaches available to select neutralizing mAbs for emerging arbovirus infections and the next-generation strategies to obtain highly effective and potent mAbs. The characteristics of mAbs developed as prophylactic and therapeutic antiviral agents for dengue, Zika, chikungunya, West Nile and tick-borne encephalitis virus are presented, as well as the protective effect demonstrated in animal model studies.<\/jats:p>","DOI":"10.3390\/v15112177","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:50:42Z","timestamp":1698670242000},"page":"2177","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections"],"prefix":"10.3390","volume":"15","author":[{"given":"Leonardo F.","family":"Ormundo","sequence":"first","affiliation":[{"name":"Biopharmaceuticals Laboratory, Instituto Butantan, S\u00e3o Paulo 05503-900, Brazil"},{"name":"The Interunits Graduate Program in Biotechnology, University of S\u00e3o Paulo, S\u00e3o Paulo 05503-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina T.","family":"Barreto","sequence":"additional","affiliation":[{"name":"Biopharmaceuticals Laboratory, Instituto Butantan, S\u00e3o Paulo 05503-900, Brazil"},{"name":"The Interunits Graduate Program in Biotechnology, University of S\u00e3o Paulo, S\u00e3o Paulo 05503-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9647-7687","authenticated-orcid":false,"given":"Lilian R.","family":"Tsuruta","sequence":"additional","affiliation":[{"name":"Biopharmaceuticals Laboratory, Instituto Butantan, S\u00e3o Paulo 05503-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/COH.0000000000000154","article-title":"History of Passive Antibody Administration for Prevention and Treatment of Infectious Diseases","volume":"10","author":"Graham","year":"2015","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrmicro974","article-title":"Passive Antibody Therapy for Infectious Diseases","volume":"2","author":"Casadevall","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41573-022-00495-3","article-title":"Antibodies to Combat Viral Infections: Development Strategies and Progress","volume":"21","author":"Pantaleo","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ogunlade, S.T., Meehan, M.T., Adekunle, A.I., Rojas, D.P., Adegboye, O.A., and McBryde, E.S. (2021). A Review: Aedes-Borne Arboviral Infections, Controls and Wolbachia-Based Strategies. Vaccines, 9.","DOI":"10.3390\/vaccines9010032"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.onehlt.2017.06.001","article-title":"Emerging Arboviruses: Why Today?","volume":"4","author":"Gould","year":"2017","journal-title":"One Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jinf.2016.02.017","article-title":"17D Yellow Fever Vaccine Elicits Comparable Long-Term Immune Responses in Healthy Individuals and Immune-Compromised Patients","volume":"72","author":"Wieten","year":"2016","journal-title":"J. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcma.2014.12.009","article-title":"Current Recommendations for the Japanese Encephalitis Vaccine","volume":"78","author":"Chen","year":"2015","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2019.01.014","article-title":"Tick-Borne Encephalitis in Europe and Russia: Review of Pathogenesis, Clinical Features, Therapy, and Vaccines","volume":"164","author":"Ruzek","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_9","first-page":"001831","article-title":"Challenges on the Development of a Dengue Vaccine: A Comprehensive Review of the State of the Art","volume":"104","year":"2023","journal-title":"J. Gen. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coviro.2020.07.006","article-title":"Mapping the Diverse Structural Landscape of the Flavivirus Antibody Repertoire","volume":"45","author":"Sevvana","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41579-022-00825-7","article-title":"A Molecular Understanding of Alphavirus Entry and Antibody Protection","volume":"21","author":"Kim","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity","volume":"256","author":"Milstein","year":"1975","journal-title":"Nature"},{"key":"ref_13","first-page":"21","article-title":"A U.S. Clinical Study of Orthoclone OKT3 in Renal Transplantation","volume":"19","author":"Norman","year":"1987","journal-title":"Transplant. Proc."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"B\u00f6ldicke, T. (2018). Antibody Engineering, InTech.","DOI":"10.5772\/65238"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nagano, K., and Tsutsumi, Y. (2021). Phage Display Technology as a Powerful Platform for Antibody Drug Discovery. Viruses, 13.","DOI":"10.3390\/v13020178"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"106639","DOI":"10.1016\/j.intimp.2020.106639","article-title":"Hybridoma Technology a Versatile Method for Isolation of Monoclonal Antibodies, Its Applicability across Species, Limitations, Advancement and Future Perspectives","volume":"85","author":"Parray","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Smith, S.A., and Crowe, J.E. (2015). Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies. Microbiol. Spectr., 3.","DOI":"10.1128\/microbiolspec.AID-0027-2014"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-61779-931-0_10","article-title":"Immortalization of Human B Cells: Analysis of B Cell Repertoire and Production of Human Monoclonal Antibodies","volume":"Volume 901","author":"Proetzel","year":"2012","journal-title":"Antibody Methods and Protocols"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/269420a0","article-title":"EB Virus-Induced B Lymphocyte Cell Lines Producing Specific Antibody","volume":"269","author":"Steinitz","year":"1977","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4049\/jimmunol.127.4.1275","article-title":"Requirements for the Establishment of High-Titered Human Monoclonal Antibodies against Tetanus Toxoid Using the Epstein-Barr Virus Technique","volume":"127","author":"Kozbor","year":"1981","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An Efficient Method to Make Human Monoclonal Antibodies from Memory B Cells: Potent Neutralization of SARS Coronavirus","volume":"10","author":"Traggiai","year":"2004","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nm.2071","article-title":"Generation of Stable Monoclonal Antibody\u2013Producing B Cell Receptor\u2013Positive Human Memory B Cells by Genetic Programming","volume":"16","author":"Kwakkenbos","year":"2010","journal-title":"Nat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/JVI.06335-11","article-title":"Persistence of Circulating Memory B Cell Clones with Potential for Dengue Virus Disease Enhancement for Decades Following Infection","volume":"86","author":"Smith","year":"2012","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1073\/pnas.81.21.6851","article-title":"Chimeric Human Antibody Molecules: Mouse Antigen-Binding Domains with Human Constant Region Domains","volume":"81","author":"Morrison","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Janda, A., Bowen, A., Greenspan, N.S., and Casadevall, A. (2016). Ig Constant Region Effects on Variable Region Structure and Function. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00022"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13048","DOI":"10.1016\/S0021-9258(18)99982-5","article-title":"Isotype Choice for Chimeric Antibodies Affects Binding Properties","volume":"269","author":"Morelock","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Torres, M., Fernandez-Fuentes, N., Fiser, A., and Casadevall, A. (2007). Exchanging Murine and Human Immunoglobulin Constant Chains Affects the Kinetics and Thermodynamics of Antigen Binding and Chimeric Antibody Autoreactivity. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0001310"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.4049\/jimmunol.169.3.1379","article-title":"Isotype Can Affect the Fine Specificity of an Antibody for a Polysaccharide Antigen","volume":"169","author":"McLean","year":"2002","journal-title":"J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2005.01.001","article-title":"Immunogenicity of Engineered Antibodies","volume":"36","author":"Hwang","year":"2005","journal-title":"Methods"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/321522a0","article-title":"Replacing the Complementarity-Determining Regions in a Human Antibody with Those from a Mouse","volume":"321","author":"Jones","year":"1986","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0161-5890(03)00022-1","article-title":"Humanization of the Anti-CD18 Antibody 6.7: An Unexpected Effect of a Framework Residue in Binding to Antigen","volume":"39","author":"Caldas","year":"2003","journal-title":"Mol. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"10029","DOI":"10.1073\/pnas.86.24.10029","article-title":"A Humanized Antibody That Binds to the Interleukin 2 Receptor","volume":"86","author":"Queen","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1074\/jbc.M706190200","article-title":"Thermodynamic Consequences of Mutations in Vernier Zone Residues of a Humanized Anti-Human Epidermal Growth Factor Receptor Murine Antibody, 528","volume":"283","author":"Makabe","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymeth.2005.01.007","article-title":"Design of Humanized Antibodies: From Anti-Tac to Zenapax","volume":"36","author":"Tsurushita","year":"2005","journal-title":"Methods"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/02648725.2013.801235","article-title":"Antibody Humanization Methods\u2014A Review and Update","volume":"29","author":"Safdari","year":"2013","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0959-440X(95)80027-1","article-title":"Phage Display: Protein Engineering by Directed Evolution","volume":"5","author":"Hoess","year":"1995","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1515\/hsz-2020-0377","article-title":"Antibody Display Technologies: Selecting the Cream of the Crop","volume":"403","author":"Valldorf","year":"2022","journal-title":"Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ledsgaard, L., Kilstrup, M., Karatt-Vellatt, A., McCafferty, J., and Laustsen, A. (2018). Basics of Antibody Phage Display Technology. Toxins, 10.","DOI":"10.3390\/toxins10060236"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nbt.1791","article-title":"Beyond Natural Antibodies: The Power of in Vitro Display Technologies","volume":"29","author":"Bradbury","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.4001944","article-title":"Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on the Virion Surface","volume":"228","author":"Smith","year":"1985","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/348552a0","article-title":"Phage Antibodies: Filamentous Phage Displaying Antibody Variable Domains","volume":"348","author":"McCafferty","year":"1990","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Jaroszewicz, W., Morcinek-Or\u0142owska, J., Pierzynowska, K., Gaffke, L., and W\u0119grzyn, G. (2022). Phage Display and Other Peptide Display Technologies. FEMS Microbiol. Rev., 46.","DOI":"10.1093\/femsre\/fuab052"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"112901","DOI":"10.1016\/j.jim.2020.112901","article-title":"Generation of a Cost-Effective Cell Line for Support of High-Throughput Isolation of Primary Human B Cells and Monoclonal Neutralizing Antibodies","volume":"488","author":"Whaley","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target","volume":"326","author":"Walker","year":"2009","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/19420862.2015.1109757","article-title":"Rapid Isolation of Dengue-Neutralizing Antibodies from Single Cell-Sorted Human Antigen-Specific Memory B-Cell Cultures","volume":"8","author":"Cox","year":"2016","journal-title":"mAbs"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1016\/j.cell.2022.10.023","article-title":"A Zika Virus-Specific IgM Elicited in Pregnancy Exhibits Ultrapotent Neutralization","volume":"185","author":"Singh","year":"2022","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, Cross-Reactivity, and Function of Antibodies Elicited by Zika Virus Infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/eji.201343917","article-title":"Single-cell Based High-throughput Sequencing of Full-length Immunoglobulin Heavy and Light Chain Genes","volume":"44","author":"Busse","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jviromet.2009.02.014","article-title":"High-Throughput Isolation of Immunoglobulin Genes from Single Human B Cells and Expression as Monoclonal Antibodies","volume":"158","author":"Liao","year":"2009","journal-title":"J. Virol. Methods"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3285","article-title":"Tools to Therapeutically Harness the Human Antibody Response","volume":"12","author":"Wilson","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.it.2021.10.008","article-title":"Single B Cell Technologies for Monoclonal Antibody Discovery","volume":"42","author":"Pedrioli","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-020-0998-x","article-title":"Rapid Isolation and Profiling of a Diverse Panel of Human Monoclonal Antibodies Targeting the SARS-CoV-2 Spike Protein","volume":"26","author":"Zost","year":"2020","journal-title":"Nat. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/19420862.2019.1624126","article-title":"Rapid Single B Cell Antibody Discovery Using Nanopens and Structured Light","volume":"11","author":"Winters","year":"2019","journal-title":"mAbs"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"821729","DOI":"10.3389\/fimmu.2021.821729","article-title":"Single-Cell Technologies for the Study of Antibody-Secreting Cells","volume":"12","author":"Broketa","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1039\/C5IB00169B","article-title":"Neutralizing Antibodies against West Nile Virus Identified Directly from Human B Cells by Single-Cell Analysis and next Generation Sequencing","volume":"7","author":"Tsioris","year":"2015","journal-title":"Integr. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41551-020-0594-x","article-title":"Integrated Pipeline for the Accelerated Discovery of Antiviral Antibody Therapeutics","volume":"4","author":"Gilchuk","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cell.2019.11.003","article-title":"High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity","volume":"179","author":"Setliff","year":"2019","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41587-020-0466-7","article-title":"High-Throughput Single-Cell Activity-Based Screening and Sequencing of Antibodies Using Droplet Microfluidics","volume":"38","author":"Woolfe","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1729683","DOI":"10.1080\/19420862.2020.1729683","article-title":"Understanding the Human Antibody Repertoire","volume":"12","author":"Rees","year":"2020","journal-title":"mAbs"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-immunol-042718-041309","article-title":"Human Antibodies for Viral Infections","volume":"40","author":"Crowe","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The Continued Threat of Emerging Flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41590-018-0210-3","article-title":"The Immune Response against Flaviviruses","volume":"19","author":"Mongkolsapaya","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e2100","DOI":"10.1002\/rmv.2100","article-title":"The Role of Anti-flavivirus Humoral Immune Response in Protection and Pathogenesis","volume":"30","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Tanabe, I.S.B., Tanabe, E.L.L., Santos, E.C., Martins, W.V., Ara\u00fajo, I.M.T.C., Cavalcante, M.C.A., Lima, A.R.V., C\u00e2mara, N.O.S., Anderson, L., and Yunusov, D. (2018). Cellular and Molecular Immune Response to Chikungunya Virus Infection. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00345"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1099\/jgv.0.000249","article-title":"Alphavirus RNA Synthesis and Non-Structural Protein Functions","volume":"96","author":"Rupp","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_66","unstructured":"(2023, July 20). Dengue and Severe Dengue. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.146.1.201","article-title":"Dengue Viruses and Mononuclear Phagocytes. I. Infection Enhancement by Non-Neutralizing Antibody","volume":"146","author":"Halstead","year":"1977","journal-title":"J. Exp. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to Dengue Virus: A Tale of Original Antigenic Sin and Tropical Cytokine Storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_70","unstructured":"(2023, August 31). AbViro LLC A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Determine the Safety and Pharmacokinetics of AV-1 in Healthy Male and Female Adult Subjects, Available online: clinicaltrials.gov."},{"key":"ref_71","unstructured":"Serum Institute of India Pvt. Ltd (2023, August 31). A Phase I, Partially Blind (Observer-Blind), Randomized, Single Dose Ascending Study of Dengue Monoclonal Antibody (Dengushield) in Healthy Adults, Available online: clinicaltrials.gov."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2006.09.009","article-title":"The Envelope Glycoprotein Domain III of Dengue Virus Serotypes 1 and 2 Inhibit Virus Entry","volume":"9","author":"Chin","year":"2007","journal-title":"Microbes Infect."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/JVI.78.1.378-388.2004","article-title":"An External Loop Region of Domain III of Dengue Virus Type 2 Envelope Protein Is Involved in Serotype-Specific Binding to Mosquito but Not Mammalian Cells","volume":"78","author":"Hung","year":"2004","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0882-4010(87)90056-8","article-title":"Profiles of Antibody-Dependent Enhancement of Dengue Virus Type 2 Infection","volume":"3","author":"Morens","year":"1987","journal-title":"Microb. Pathog."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0168-1656(99)00037-1","article-title":"A Recombinant Fab Neutralizes Dengue Virus in Vitro","volume":"69","author":"Thullier","year":"1999","journal-title":"J. Biotechnol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Deng, Y.-Q., Dai, J.-X., Ji, G.-H., Jiang, T., Wang, H.-J., Yang, H., Tan, W.-L., Liu, R., Yu, M., and Ge, B.-X. (2011). A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody That Recognizes a Novel Epitope within the Fusion Loop of E Protein. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016059"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"12987","DOI":"10.1038\/s41598-021-92403-9","article-title":"An Affinity-Matured Human Monoclonal Antibody Targeting Fusion Loop Epitope of Dengue Virus with in Vivo Therapeutic Potency","volume":"11","author":"Kotaki","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41541-016-0003-3","article-title":"A Potent Neutralizing Antibody with Therapeutic Potential against All Four Serotypes of Dengue Virus","volume":"2","author":"Xu","year":"2017","journal-title":"Npj Vaccines"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"107584","DOI":"10.1016\/j.celrep.2020.107584","article-title":"A Human Antibody Neutralizes Different Flaviviruses by Using Different Mechanisms","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Rep."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Li, L., Meng, W., Horton, M., DiStefano, D.R., Thoryk, E.A., Pfaff, J.M., Wang, Q., Salazar, G.T., Barnes, T., and Doranz, B.J. (2019). Potent Neutralizing Antibodies Elicited by Dengue Vaccine in Rhesus Macaque Target Diverse Epitopes. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007716"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12985-017-0856-8","article-title":"Characterization and Epitope Mapping of Dengue Virus Type 1 Specific Monoclonal Antibodies","volume":"14","author":"Chen","year":"2017","journal-title":"Virol. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbrc.2012.06.057","article-title":"Human Monoclonal Antibodies to Neutralize All Dengue Virus Serotypes Using Lymphocytes from Patients at Acute Phase of the Secondary Infection","volume":"423","author":"Setthapramote","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.4049\/jimmunol.1201688","article-title":"Plasmablasts Generated during Repeated Dengue Infection Are Virus Glycoprotein\u2013Specific and Bind to Multiple Virus Serotypes","volume":"189","author":"Xu","year":"2012","journal-title":"J. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A New Class of Highly Potent, Broadly Neutralizing Antibodies Isolated from Viremic Patients Infected with Dengue Virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1038\/s41598-017-07308-3","article-title":"Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection","volume":"7","author":"Lai","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Tien, S.-M., Chang, P.-C., Lai, Y.-C., Chuang, Y.-C., Tseng, C.-K., Kao, Y.-S., Huang, H.-J., Hsiao, Y.-P., Liu, Y.-L., and Lin, H.-H. (2022). Therapeutic Efficacy of Humanized Monoclonal Antibodies Targeting Dengue Virus Nonstructural Protein 1 in the Mouse Model. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010469"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Chouin-Carneiro, T., Vega-Rua, A., Vazeille, M., Yebakima, A., Girod, R., Goindin, D., Dupont-Rouzeyrol, M., Louren\u00e7o-de-Oliveira, R., and Failloux, A.-B. (2016). Differential Susceptibilities of Aedes Aegypti and Aedes Albopictus from the Americas to Zika Virus. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004543"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Counotte, M.J., Kim, C.R., Wang, J., Bernstein, K., Deal, C.D., Broutet, N.J.N., and Low, N. (2018). Sexual Transmission of Zika Virus and Other Flaviviruses: A Living Systematic Review. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002611"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(16)30058-7","article-title":"Guillain-Barr\u00e9 Syndrome Associated with Zika Virus Infection","volume":"387","author":"Brasil","year":"2016","journal-title":"Lancet"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.chom.2017.01.004","article-title":"Zika Virus Pathogenesis and Tissue Tropism","volume":"21","author":"Miner","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1038\/s41467-019-11866-7","article-title":"Zika Virus Replicates in Adult Human Brain Tissue and Impairs Synapses and Memory in Mice","volume":"10","author":"Figueiredo","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.chom.2016.07.002","article-title":"Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission","volume":"20","author":"Tabata","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(17)30727-2","article-title":"Association between Microcephaly, Zika Virus Infection, and Other Risk Factors in Brazil: Final Report of a Case-Control Study","volume":"18","author":"Ximenes","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(16)30883-2","article-title":"Pathology of Congenital Zika Syndrome in Brazil: A Case Series","volume":"388","author":"Martines","year":"2016","journal-title":"Lancet"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamapediatrics.2017.0002","article-title":"Bridging Knowledge Gaps to Understand How Zika Virus Exposure and Infection Affect Child Development","volume":"171","author":"Kapogiannis","year":"2017","journal-title":"JAMA Pediatr."},{"key":"ref_97","unstructured":"Tychan Pte Ltd (2023, August 31). Phase 1 Time Lagged, Parallel-Group, Randomized, Placebo-Controlled, Single-Blind, Single Ascending Dose Study of Tyzivumab in ZIKV Infected Patients, Available online: clinicaltrials.gov."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1073\/pnas.1607931113","article-title":"Human Antibody Responses after Dengue Virus Infection Are Highly Cross-Reactive to Zika Virus","volume":"113","author":"Priyamvada","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e124588","DOI":"10.1172\/jci.insight.124588","article-title":"Human Antibody Response to Zika Targets Type-Specific Quaternary Structure Epitopes","volume":"4","author":"Collins","year":"2019","journal-title":"JCI Insight"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"eaan6809","DOI":"10.1126\/sciimmunol.aan6809","article-title":"Zika Virus Activates de Novo and Cross-Reactive Memory B Cell Responses in Dengue-Experienced Donors","volume":"2","author":"Rogers","year":"2017","journal-title":"Sci. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue Virus Sero-Cross-Reactivity Drives Antibody-Dependent Enhancement of Infection with Zika Virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika Virus Pathogenesis by Preexisting Antiflavivirus Immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing Human Antibodies Prevent Zika Virus Replication and Fetal Disease in Mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.omtm.2020.06.011","article-title":"Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection","volume":"18","author":"Erasmus","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.celrep.2018.10.031","article-title":"A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-Human Primates","volume":"25","author":"Keeffe","year":"2018","journal-title":"Cell Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"369ra179","DOI":"10.1126\/scitranslmed.aai8336","article-title":"Molecular Determinants of Human Neutralizing Antibodies Isolated from a Patient Infected with Zika Virus","volume":"8","author":"Wang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ni.3849","article-title":"Human Antibodies to the Dengue Virus E-Dimer Epitope Have Therapeutic Activity against Zika Virus Infection","volume":"18","author":"Fernandez","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41591-018-0056-0","article-title":"Therapeutic and Protective Efficacy of a Dengue Antibody against Zika Infection in Rhesus Monkeys","volume":"24","author":"Abbink","year":"2018","journal-title":"Nat. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e92428","DOI":"10.1172\/jci.insight.92428","article-title":"Cross-Reactive Dengue Human Monoclonal Antibody Prevents Severe Pathologies and Death from Zika Virus Infections","volume":"2","author":"Kam","year":"2017","journal-title":"JCI Insight"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1038\/s41467-020-19096-y","article-title":"Antibodies Targeting Epitopes on the Cell-Surface Form of NS1 Protect against Zika Virus Infection during Pregnancy","volume":"11","author":"Wessel","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e2100104118","DOI":"10.1073\/pnas.2100104118","article-title":"Near-Germline Human Monoclonal Antibodies Neutralize and Protect against Multiple Arthritogenic Alphaviruses","volume":"118","author":"Malonis","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/infdis\/jis674","article-title":"Use of Human Monoclonal Antibodies to Treat Chikungunya Virus Infection","volume":"207","author":"Fric","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Pal, P., Dowd, K.A., Brien, J.D., Edeling, M.A., Gorlatov, S., Johnson, S., Lee, I., Akahata, W., Nabel, G.J., and Richter, M.K.S. (2013). Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003312"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.chom.2015.06.009","article-title":"Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus","volume":"18","author":"Smith","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Quiroz, J.A., Malonis, R.J., Thackray, L.B., Cohen, C.A., Pallesen, J., Jangra, R.K., Brown, R.S., Hofmann, D., Holtsberg, F.W., and Shulenin, S. (2019). Human Monoclonal Antibodies against Chikungunya Virus Target Multiple Distinct Epitopes in the E1 and E2 Glycoproteins. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1008061"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1743-422X-11-183","article-title":"Long-Term Persistence of Chikungunya Virus Neutralizing Antibodies in Human Populations of North Eastern Thailand","volume":"11","author":"Nitatpattana","year":"2014","journal-title":"Virol. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e02449-17","DOI":"10.1128\/mBio.02449-17","article-title":"Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models","volume":"9","author":"Langsjoen","year":"2018","journal-title":"mBio"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11262-020-01820-x","article-title":"Prophylactic Strategies to Control Chikungunya Virus Infection","volume":"57","author":"Hucke","year":"2021","journal-title":"Virus Genes."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.1128\/JVI.01032-14","article-title":"Chikungunya Viruses That Escape Monoclonal Antibody Therapy Are Clinically Attenuated, Stable, and Not Purified in Mosquitoes","volume":"88","author":"Pal","year":"2014","journal-title":"J. Virol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"105295","DOI":"10.1016\/j.antiviral.2022.105295","article-title":"Therapeutic and Prophylactic Treatment with a Virus-Specific Antibody Is Highly Effective in Rodent Models of Chikungunya Infection and Disease","volume":"202","author":"Julander","year":"2022","journal-title":"Antivir. Res."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Broeckel, R., Fox, J.M., Haese, N., Kreklywich, C.N., Sukulpovi-Petty, S., Legasse, A., Smith, P.P., Denton, M., Corvey, C., and Krishnan, S. (2017). Therapeutic Administration of a Recombinant Human Monoclonal Antibody Reduces the Severity of Chikungunya Virus Disease in Rhesus Macaques. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005637"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"14364","DOI":"10.1128\/JVI.01943-14","article-title":"Exposure of Epitope Residues on the Outer Face of the Chikungunya Virus Envelope Trimer Determines Antibody Neutralizing Efficacy","volume":"88","author":"Fong","year":"2014","journal-title":"J. Virol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.molimm.2018.11.016","article-title":"Selection and Characterization of Protective Anti-Chikungunya Virus Single Domain Antibodies","volume":"105","author":"Liu","year":"2019","journal-title":"Mol. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/j.cell.2021.07.006","article-title":"Pan-Protective Anti-Alphavirus Human Antibodies Target a Conserved E1 Protein Epitope","volume":"184","author":"Kim","year":"2021","journal-title":"Cell"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-065X.2008.00676.x","article-title":"The Structural Immunology of Antibody Protection against West Nile Virus","volume":"225","author":"Diamond","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1743-422X-9-81","article-title":"West Nile Virus: Characterization and Diagnostic Applications of Monoclonal Antibodies","volume":"9","author":"Lelli","year":"2012","journal-title":"Virol. J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"036","DOI":"10.4172\/jaa.1000005","article-title":"Human Monoclonal Fab Antibodies Against West Nile Virus and Its Neutralizing Activity Analyzed in Vitro and in Vivo","volume":"1","author":"Duan","year":"2009","journal-title":"J. Antivir. Antiretrovir."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Barzon, L., Pacenti, M., Montarsi, F., Fornasiero, D., Gobbo, F., Quaranta, E., Monne, I., Fusaro, A., Volpe, A., and Sinigaglia, A. (2022). Rapid Spread of a New West Nile Virus Lineage 1 Associated with Increased Risk of Neuroinvasive Disease during a Large Outbreak in Italy in 2022. J. Travel Med., taac125.","DOI":"10.1093\/jtm\/taac125"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Habarugira, G., Suen, W.W., Hobson-Peters, J., Hall, R.A., and Bielefeldt-Ohmann, H. (2020). West Nile Virus: An Update on Pathobiology, Epidemiology, Diagnostics, Control and \u201cOne Health\u201d Implications. Pathogens, 9.","DOI":"10.3390\/pathogens9070589"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural Basis of West Nile Virus Neutralization by a Therapeutic Antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a Humanized Monoclonal Antibody with Therapeutic Potential against West Nile Virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/508293","article-title":"Humanized Monoclonal Antibody against West Nile Virus Envelope Protein Administered after Neuronal Infection Protects against Lethal Encephalitis in Hamsters","volume":"194","author":"Morrey","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1128\/AAC.00147-07","article-title":"Defining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster Model","volume":"51","author":"Morrey","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/599794","article-title":"Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus","volume":"200","author":"Zhang","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/AAC.01178-09","article-title":"Safety and Pharmacokinetics of Single Intravenous Dose of MGAWN1, a Novel Monoclonal Antibody to West Nile Virus","volume":"54","author":"Beigel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41564-018-0283-7","article-title":"A Potently Neutralizing Human Monoclonal Antibody Targeting the West Nile Virus E Protein Preferentially Recognizes Mature Virions","volume":"4","author":"Goo","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1128\/JVI.00551-06","article-title":"Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus","volume":"80","author":"Throsby","year":"2006","journal-title":"J. Virol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1128\/JVI.00286-09","article-title":"Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step","volume":"83","author":"Vogt","year":"2009","journal-title":"J. Virol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"18950","DOI":"10.1073\/pnas.1011036107","article-title":"Neutralization of West Nile Virus by Cross-Linking of Its Surface Proteins with Fab Fragments of the Human Monoclonal Antibody CR4354","volume":"107","author":"Kaufmann","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2018.04.011","article-title":"Human Monoclonal Antibodies against West Nile Virus from Japanese Encephalitis-Vaccinated Volunteers","volume":"154","author":"Ozawa","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_142","unstructured":"(2023, September 07). A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults, Available online: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT00515385?term=nct00515385&draw=2&rank=1."},{"key":"ref_143","unstructured":"(2023, September 07). Treatment of West Nile Virus With MGAWN1 (PARADIGM), Available online: https:\/\/clinicaltrials.gov\/study\/NCT00927953."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"14606","DOI":"10.1128\/JVI.79.23.14606-14613.2005","article-title":"Protective and Therapeutic Capacity of Human Single-Chain Fv-Fc Fusion Proteins against West Nile Virus","volume":"79","author":"Gould","year":"2005","journal-title":"J. Virol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tmaid.2010.06.004","article-title":"Tick-Borne Encephalitis: Pathogenesis and Clinical Implications","volume":"8","author":"Dobler","year":"2010","journal-title":"Travel. Med. Infect. Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2019.01.004","article-title":"Tick-Borne Encephalitis in Europe: A Brief Update on Epidemiology, Diagnosis, Prevention, and Treatment","volume":"62","author":"Riccardi","year":"2019","journal-title":"Eur. J. Intern. Med."},{"key":"ref_147","first-page":"218","article-title":"Interaction of Tick\/Borne Encephalitis Virus with Mouse Peritoneal Macrophages. The Effect of Antiviral Antibody and Lectin","volume":"35","author":"Grubhoffer","year":"1991","journal-title":"Acta Virol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1128\/jvi.71.4.2921-2927.1997","article-title":"Pre- and Postexposure Protection by Passive Immunoglobulin but No Enhancement of Infection with a Flavivirus in a Mouse Model","volume":"71","author":"Kreil","year":"1997","journal-title":"J. Virol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ttbdis.2016.11.007","article-title":"Tick-Borne Encephalitis Virus Neutralization by High Dose Intravenous Immunoglobulin","volume":"8","author":"Elsterova","year":"2017","journal-title":"Ticks Tick-Borne Dis."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"105504","DOI":"10.1016\/j.antiviral.2022.105504","article-title":"New Directions in the Experimental Therapy of Tick-Borne Encephalitis","volume":"210","author":"Eyer","year":"2023","journal-title":"Antivir. Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-1702(93)90011-B","article-title":"Epitope Analysis of Tick-Borne Encephalitis (TBE) Complex Viruses Using Monoclonal Antibodies to Envelope Glycoprotein of TBE Virus (Persulcatus Subtype)","volume":"30","author":"Tsekhanovskaya","year":"1993","journal-title":"Virus Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.vaccine.2020.04.051","article-title":"Characterization of Neutralizing Monoclonal Antibody against Tick-Borne Encephalitis Virus in Vivo","volume":"38","author":"Matveev","year":"2020","journal-title":"Vaccine"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.vaccine.2014.05.012","article-title":"A Protective Chimeric Antibody to Tick-Borne Encephalitis Virus","volume":"32","author":"Baykov","year":"2014","journal-title":"Vaccine"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Matveev, A.L., Kozlova, I.V., Stronin, O.V., Khlusevich, Y.A., Doroshchenko, E.K., Baykov, I.K., Lisak, O.V., Emelyanova, L.A., Suntsova, O.V., and Matveeva, V.A. (2019). Post-Exposure Administration of Chimeric Antibody Protects Mice against European, Siberian, and Far-Eastern Subtypes of Tick-Borne Encephalitis Virus. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0215075"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1016\/j.vaccine.2010.05.060","article-title":"Chimeric Antibodies against Tick-Borne Encephalitis Virus","volume":"28","author":"Levanov","year":"2010","journal-title":"Vaccine"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e20210236","DOI":"10.1084\/jem.20210236","article-title":"Broad and Potent Neutralizing Human Antibodies to Tick-Borne Flaviviruses Protect Mice from Disease","volume":"218","author":"Agudelo","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"E1555","DOI":"10.1073\/pnas.1303645110","article-title":"Redesign of a Cross-Reactive Antibody to Dengue Virus with Broad-Spectrum Activity and Increased in Vivo Potency","volume":"110","author":"Tharakaraman","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2015.06.057","article-title":"Structure-Guided Design of an Anti-Dengue Antibody Directed to a Non-Immunodominant Epitope","volume":"162","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.antiviral.2017.05.007","article-title":"Preclinical Evaluation of VIS513, a Therapeutic Antibody against Dengue Virus, in Non-Human Primates","volume":"144","author":"Ong","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Budigi, Y., Ong, E.Z., Robinson, L.N., Ong, L.C., Rowley, K.J., Winnett, A., Tan, H.C., Hobbie, S., Shriver, Z., and Babcock, G.J. (2018). Neutralization of Antibody-Enhanced Dengue Infection by VIS513, a Pan Serotype Reactive Monoclonal Antibody Targeting Domain III of the Dengue E Protein. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006209"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"eaan8184","DOI":"10.1126\/scitranslmed.aan8184","article-title":"Neutralizing Human Monoclonal Antibodies Prevent Zika Virus Infection in Macaques","volume":"9","author":"Magnani","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2017.09.002","article-title":"A Human Bi-Specific Antibody against Zika Virus with High Therapeutic Potential","volume":"171","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.molimm.2014.09.017","article-title":"Highly Reduced Binding to High and Low Affinity Mouse Fc Gamma Receptors by L234A\/L235A and N297A Fc Mutations Engineered into Mouse IgG2a","volume":"63","author":"Arduin","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/protein\/gzw040","article-title":"Novel Human IgG1 and IgG4 Fc-Engineered Antibodies with Completely Abolished Immune Effector Functions","volume":"29","author":"Schlothauer","year":"2016","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/s41467-018-04056-4","article-title":"Fetal Demise and Failed Antibody Therapy during Zika Virus Infection of Pregnant Macaques","volume":"9","author":"Magnani","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Baykov, I.K., Desyukevich, P.Y., Mikhaylova, E.E., Kurchenko, O.M., and Tikunova, N.V. (2021). Computational and Rational Design of Single-Chain Antibody against Tick-Borne Encephalitis Virus for Modifying Its Specificity. Viruses, 13.","DOI":"10.3390\/v13081494"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/11\/2177\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:14:03Z","timestamp":1760130843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/11\/2177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":166,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["v15112177"],"URL":"https:\/\/doi.org\/10.3390\/v15112177","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]}}}